Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 46
Filtrar
1.
Ter Arkh ; 80(10): 21-6, 2008.
Artículo en Ruso | MEDLINE | ID: mdl-19105408

RESUMEN

AIM: To study effects of avandia and its combination with metformine (avandamet) on secretion of fat tissue hormones. MATERIAL AND METHODS: The examination protocol for 42 patients with type 2 diabetes mellitus (DM) aged 62.4 +/- 7.7 years comprised tests for blood levels of leptin, soluble receptor to leptin, insulin, grelin, resistin and adiponectine. RESULTS: The treatment resulted in reduction of fasting glycemia from 10.69 +/- 2.54 to 8.42 +/- 1.73 mmol/l, of glycosilated hemoglobin--from 8.1 + 1.6 to 7.75%, immunoreactive insulin--from 19.1 +/- 8.3 to 12.0 +/- 6.5 mg/ml, grelin--from 21.7 +/- 14.6 to 17.3 +/- 13.7 mg/ml, leptin--from 40.3 +/- 24.2 to 26.9 +/- 15.4 mg/ml, soluble receptor to leptin--from 17.9 +/- 4.5 to 13.1 +/- 3.5 mg/ml. LDLP and HDLP cholesterol was high. CONCLUSION: Avandia and avandamet are effective antidiabetic drugs with a beneficial effect on secretion of fat tissue hormones.


Asunto(s)
Adiponectina/metabolismo , Tejido Adiposo/metabolismo , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Fibrinolíticos/uso terapéutico , Ghrelina/metabolismo , Hipoglucemiantes/uso terapéutico , Insulina/metabolismo , Leptina/metabolismo , Metformina/uso terapéutico , Resistina/metabolismo , Tiazoles/uso terapéutico , Tiazolidinedionas/uso terapéutico , Combinación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Rosiglitazona
2.
Ter Arkh ; 74(10): 25-7, 2002.
Artículo en Ruso | MEDLINE | ID: mdl-12469626

RESUMEN

AIM: Distribution of alleles of tetranucleotide microsatellite D6S392 located nearby the gene of Mn-dependent superoxide dismutase (SOD2) was studied in healthy donors (n = 143), patients with insulin-dependent (n = 166) and insulin-independent (n = 101) diabetes mellitus (IDDM and IIDM). MATERIALS AND METHODS: Alleles of the polymorphic locus D6S392 were amplified using polymerase chain reaction (PCR) on the basis of genome DNA isolated from the venous blood of the examinees. PCR products were analysed with gel-electrophoresis in polyacrylamide gel. Significance of differences of allele and genotypes distribution in the population control and patients were assessed with Fisher's criterion and Bonferroni's corrections. RESULTS: Locus D6S392 contains 31 allele from 210 to 330 pn in length and 37 to 67 tandem repeats. Compared to controls, IDDM patients had less frequent incidence of low molecular allele 41 and 42 as well as allele 62. CONCLUSION: Polymorphic locus D6S392 is closely associated with development of DM in Moscow population. This may indicate possible participation of the gene SOD2 in development of this pathology.


Asunto(s)
Diabetes Mellitus Tipo 1/genética , Polimorfismo Genético , Superóxido Dismutasa/genética , Adolescente , Adulto , Alelos , Secuencia de Bases , Cartilla de ADN , Diabetes Mellitus Tipo 1/enzimología , Femenino , Humanos , Masculino , Moscú , Reacción en Cadena de la Polimerasa
4.
Genetika ; 36(3): 423-6, 2000 Mar.
Artículo en Ruso | MEDLINE | ID: mdl-10779920

RESUMEN

The allele and genotype frequency distributions of the D11S2008 tetranucleotide microsatellite linked with the catalase (CAT) gene were compared between patients with insulin-dependent diabetes mellitus (IDDM) with (N = 72) and without (N = 82) coronary heart disease (CHD), and between IDDM patients with normal arterial tension (N = 82) and with arterial hypertension (N = 42). In total, eight alleles were found. The alleles varied in length from 120 to 148 bp and included from 15 to 22 tetranucleotide repeats. The groups did not differ in D11S2008 allele and genotype frequencies; the only exception was that the frequency of genotype 18/19 in patients with CHD (31.9%) was significantly higher than in the controls (18.3%). Thus, the D11S2008 polymorphic locus located in proximity to the catalase gene proved to be weakly associated with CHD, but not associated with arterial hypertension, in IDDM patients. Genotype 18/19 was associated with a higher risk of CHD.


Asunto(s)
Catalasa/genética , Mapeo Cromosómico , Diabetes Mellitus Tipo 2/genética , Hipertensión/genética , Isquemia Miocárdica/genética , Polimorfismo Genético , Secuencia de Bases , Cartilla de ADN , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/enzimología , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Hipertensión/complicaciones , Hipertensión/metabolismo , Moscú , Isquemia Miocárdica/complicaciones , Isquemia Miocárdica/enzimología , Reacción en Cadena de la Polimerasa
5.
Genetika ; 34(12): 1699-703, 1998 Dec.
Artículo en Ruso | MEDLINE | ID: mdl-10205747

RESUMEN

The insertion/deletion polymorphism (I/D) of the angiotensin I-converting enzyme gene (ACE) was examined in type I diabetes mellitus patients (DM) with (n = 31), or without (n = 33) retinopathy, and in type 2 DM patients with either myocardial infarction (MI; n = 75), or with (n = 37), or without (n = 178) retinopathy. No association between the ACE gene and retinopathy in type 1 and type 2 DM patients was revealed. In the type 2 DM patients with MI, a statistically significant (P < 0.05) elevation of the D allele frequency (64%) compared to that without MI (55.3%), together with statistically nonsignificant prevalence of the DD homozygotes (41% versus 30.6%) was observed. Our data indicate that the D allele (RR 1.43) and DD genotype (RR 1.75) are risk factors for myocardial infarction in the type 2 DM patients.


Asunto(s)
Diabetes Mellitus Tipo 2/genética , Retinopatía Diabética/genética , Infarto del Miocardio/genética , Peptidil-Dipeptidasa A/genética , Polimorfismo Genético , Adulto , Diabetes Mellitus Tipo 2/enzimología , Retinopatía Diabética/enzimología , Femenino , Humanos , Masculino , Infarto del Miocardio/enzimología
6.
Vestn Oftalmol ; 112(1): 40-3, 1996.
Artículo en Ruso | MEDLINE | ID: mdl-8659071

RESUMEN

Results of clinical and laboratory examinations of 161 diabetics are presented. The main factors or risk of nonproliferative diabetic retinopathy are the duration and degree of compensation of diabetes mellitus, development and stage of diabetic nephropathy, the latter factor replacing in experiments with simulation of diabetic retinopathy the level of arterial hypertension, and the blood serum content of high-density lipoprotein cholesterol and ratio of total cholesterol to high-density lipoprotein cholesterol. The factors of risk of proliferative diabetic retinopathy are duration and degree of compensation of diabetes mellitus, development and stage of diabetic retinopathy with this latter factor replacing in simulation of diabetic retinopathy the level of arterial hypertension, and the blood serum levels of triglycerides, low-density lipoprotein cholesterol, fibrinogen, soluble fibrin-monomer complexes, as well as fibrinolytic activity.


Asunto(s)
Nefropatías Diabéticas/epidemiología , Retinopatía Diabética/epidemiología , Adolescente , Adulto , Factores de Edad , Anciano , Colesterol/sangre , HDL-Colesterol/sangre , Nefropatías Diabéticas/complicaciones , Nefropatías Diabéticas/diagnóstico , Retinopatía Diabética/complicaciones , Retinopatía Diabética/diagnóstico , Humanos , Hipertensión/complicaciones , Persona de Mediana Edad , Factores de Riesgo
7.
Klin Med (Mosk) ; 73(6): 21-2, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-8691771

RESUMEN

Because little is known about disordered metabolism of uric acid as a pathogenetic mechanism of renal damage in non-insulin-dependent diabetes mellitus (NIDDM) it was studied in 75 NIDDM and 48 IDDM patients. Clinical examination of the patients included evaluation of purin metabolism according to serum uric acid, diurnal urine excretion, uric acid clearance. Hyperuricemia occurred more frequently in NIDDM. Positive correlation was observed between hyperuricosuria and the severity of diabetic nephropathy which was more pronounced in IDDM.


Asunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Nefropatías Diabéticas/diagnóstico , Hipertensión Renal/diagnóstico , Adulto , Anciano , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/orina , Diabetes Mellitus Tipo 2/orina , Nefropatías Diabéticas/orina , Femenino , Gota/diagnóstico , Gota/orina , Humanos , Hipertensión Renal/orina , Cálculos Renales/diagnóstico , Cálculos Renales/orina , Masculino , Persona de Mediana Edad , Ácido Úrico/orina
8.
Probl Endokrinol (Mosk) ; 40(6): 19-20, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-7740030

RESUMEN

Use of laser doppler flowmeter helped reveal in patients with diabetes mellitus a decrease of volumetric bloodstream in the capillaries of skin in the absence of clinical and biochemical evidence of microcirculatory disorders. Bloodstream parameters were correlated to the findings of objective methods of diagnosis at the stage of manifest clinical signs of vascular involvement of various localizations. Laser doppler flowmeter may be used for preclinical diagnosis of renal and ophthalmic involvement in diabetics with types I and II conditions as a method to monitor the therapy efficacy in patients with apparent clinical signs of microangiopathies. We should like to emphasize the possibility of mass screenings of patients and the simple technique of using the device, as well as the possibility of assessing the bloodstream not only in the skin, but in the organs and retina as well.


Asunto(s)
Angiopatías Diabéticas/diagnóstico , Flujometría por Láser-Doppler , Adolescente , Adulto , Anciano , Angiopatías Diabéticas/fisiopatología , Nefropatías Diabéticas/fisiopatología , Femenino , Tasa de Filtración Glomerular , Humanos , Masculino , Microcirculación/fisiopatología , Persona de Mediana Edad , Flujo Sanguíneo Regional , Piel/irrigación sanguínea , Factores de Tiempo
9.
Probl Endokrinol (Mosk) ; 40(2): 9-11, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-8197104

RESUMEN

Besides the known factors contributing to the pathogenesis of diabetic nephropathy, the role of immune mechanisms in types I and II diabetes is discussed of late; the contribution of autoimmune mechanisms to pathogenesis of noninsulin-dependent diabetes (NIDDM) is virtually unknown. Seventy-six patients with NIDDM and 48 with insulin-dependent condition were examined. Under study were levels of antibodies to FxIA and renal glomerular basal membrane antigens in the blood sera of donors and patients with types I and II diabetes, as well as concentrations, size, and pathogenicity of immune complexes. Antibodies to FxIA antigen were detected in patients with both types of diabetes with diabetic nephropathy. Detection of circulating antibodies to FxIA antigen in more than 70% of diabetics in the absence of protein in the urine may be used as a test system for the laboratory diagnosis of diabetic nephropathy prestage and as a criterion for prescription as early as at the initial stages of nephroprotective agents.


Asunto(s)
Diabetes Mellitus Tipo 2/inmunología , Nefropatías Diabéticas/inmunología , Adulto , Anciano , Complejo Antígeno-Anticuerpo/sangre , Autoanticuerpos/sangre , Autoantígenos/sangre , Diabetes Mellitus Tipo 1/inmunología , Complejo Antigénico de Nefritis de Heymann , Humanos , Glomérulos Renales/inmunología , Glicoproteínas de Membrana/inmunología , Persona de Mediana Edad
10.
Probl Endokrinol (Mosk) ; 39(4): 13-4, 1993.
Artículo en Ruso | MEDLINE | ID: mdl-8415519

RESUMEN

Twenty-five patients with type I diabetes mellitus (8 women and 7 men) aged 19 to 54 with a disease duration of 3 to 19 years were treated by Russian semisynthetic short-acting human insulin mono-H. The daily dose varied from 24 to 44 U. The drug therapeutic efficacy was assessed from the terms of attainment of carbohydrate metabolism compensation, glycosylated hemoglobin level, and changes in daily insulin requirement. Clinical safety of the drug was assessed from changes in antiinsulin antibody level, incidence and severity of hypoglycemia, absence of lipodystrophy and other adverse reactions. The drug was found effective for the treatment of patients with type I diabetes. Its hypoglycemic effect was similar to that of actrapid, a porcine insulin. Fractionated insulin therapy resulted in the majority of patients in a reduction of glycosylated hemoglobin level, of daily requirement in insulin, and of antiinsulin antibody titer.


Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Insulina/uso terapéutico , Adulto , Anticuerpos Monoclonales/sangre , Femenino , Humanos , Hipoglucemia/inducido químicamente , Hipoglucemia/epidemiología , Incidencia , Insulina/efectos adversos , Insulina/inmunología , Masculino , Persona de Mediana Edad
11.
Probl Endokrinol (Mosk) ; 38(6): 34-5, 1992.
Artículo en Ruso | MEDLINE | ID: mdl-1302847

RESUMEN

Stable compensation of diabetes mellitus, including normolipidemia, underlies the therapy of diabetic angiopathies. Mevacor represents a nonactive lactone form of a certain hydroxy acid, a potent inhibitor of endogenous synthesis of cholesterol, conducive to blood cholesterol reduction. The aim of the present study was the assessment of the efficacy of this drug in therapy of patients with diabetes mellitus. Ten patients were administered mevacor in a dose of 20 mg for a month. Such therapy was conducive to a significant reduction of the levels of cholesterol, LNP cholesterol, triglycerides, and cholesterol/LVP ratio. It also promoted a reduction of the content of lipid peroxidation products in the blood, these products being an active factor of vessel destruction. The levels of hydroperoxides, blood serum and red cell malonic dialdehyde, and superoxide dismutase were also reduced. These results necessitate addition of mevacor to a complex of therapy for diabetes to normalize lipid metabolism.


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Angiopatías Diabéticas/tratamiento farmacológico , Lovastatina/uso terapéutico , Adulto , Anciano , Colesterol/sangre , LDL-Colesterol/sangre , Diabetes Mellitus Tipo 2/sangre , Angiopatías Diabéticas/sangre , Humanos , Persona de Mediana Edad , Triglicéridos/sangre
14.
Ter Arkh ; 61(6): 67-9, 1989.
Artículo en Ruso | MEDLINE | ID: mdl-2799719

RESUMEN

Patients with types I and II diabetes mellitus without the clinical signs of nephroangiopathy were subjected to a comprehensive study of renal function. Using the method for determination of endogenous creatinine clearance (140 patients), radionuclide methods (in 350 patients) and beta-2-microtest (in 130 patients) the impairment of renal filtration function was established in 30.8, 67.6 and in 52% of the patients, respectively. In 16.3% of the patients, there was an impairment of the proximal part of the canaliculi. The determination of proteinuria selectivity in polyacrylamide gel revealed latent proteinuria in 70% of the patients and enabled one to specify the spectrum of uroproteins. The informative value of the methods suggested was supported by the results of morphologic studies of biopsy specimens of the kidneys and skin. The importance of the specification of the preclinical stage of diabetic nephroangiopathy was determined by the possibility of the reverse development of the pathological alterations at the given stage. The authors describe the experience gained with the correction of functional disorders by means of programmed administration of insulin using the apparatus Biostator, application of diamicron and angioprotectors.


Asunto(s)
Angiopatías Diabéticas/diagnóstico , Nefropatías Diabéticas/diagnóstico , Creatina/sangre , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 2/complicaciones , Angiopatías Diabéticas/tratamiento farmacológico , Nefropatías Diabéticas/tratamiento farmacológico , Humanos , Pruebas de Función Renal , Proteinuria/diagnóstico
15.
Ter Arkh ; 59(11): 22-6, 1987.
Artículo en Ruso | MEDLINE | ID: mdl-3327181

RESUMEN

A total of 43 patients aged 16-62 with moderately severe and severe type I diabetes mellitus of 2-27 years duration were observed. The patients were admitted to hospital with decompensation of metabolic processes. In order to achieve compensation monocomponent insulins were administered in an individual dose depending on the levels of glycemia and glucosuria and a scheme of drug administration (2 times continuously, i.v. using the Biostator apparatus). The duration of therapy was 4 months. A hypoglycemic effect in relation to immunological and hemorheological indices was assessed. A hypoglycemic effect was noted in all the patients. A positive effect of high-purity insulins on immunological and hemorheological indices was revealed. These insulins can be used for prevention of diabetic angiopathies.


Asunto(s)
Diabetes Mellitus/tratamiento farmacológico , Insulina/uso terapéutico , Adolescente , Adulto , Coagulación Sanguínea/efectos de los fármacos , Diabetes Mellitus/sangre , Diabetes Mellitus/inmunología , Esquema de Medicación , Femenino , Humanos , Insulina/aislamiento & purificación , Masculino , Persona de Mediana Edad
16.
Probl Endokrinol (Mosk) ; 32(5): 15-8, 1986.
Artículo en Ruso | MEDLINE | ID: mdl-3786296

RESUMEN

A degree of a decrease in the content of urocanic acid in washes-off from the skin surface of patients with decompensated diabetes mellitus depends on a period and gravity of disease that may be indicative of disorders of the adenylate cyclase system (or one of its links). Change in the content of urocanic acid in the epidermis of patients with diabetes mellitus treated with the Biostator apparatus, correlates with change in the content of glucagon and blood sugar. The authors discuss a possibility to use the test of urocanic acid determination for the prediction and assessment of the efficacy of therapy of patients with diabetes mellitus.


Asunto(s)
Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Epidermis/metabolismo , Imidazoles/metabolismo , Ácido Urocánico/metabolismo , Adulto , Anciano , Glucemia/metabolismo , Enfermedad Crónica , Femenino , Glucagón/sangre , Humanos , Masculino , Persona de Mediana Edad , Sudor/metabolismo , Factores de Tiempo
17.
Probl Endokrinol (Mosk) ; 31(5): 63-7, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-4070196

RESUMEN

Altogether 100 patients with insulin-dependent diabetes mellitus of a labile course were treated using the Biostator unit (artificial pancreas). The control group (20 persons) was treated with divided doses of insulin within a day. A study was made of glycemia, the range of its deviations, daily glucosuria, diuresis, the basal level of C-peptide and glucagon in the study and control groups prior to and after treatment. Statistically significant improvement of the values in the study group was observed, that, in the authors' opinion, can be attributed to the improvement of insulin-glucagon ratio at the expense fo an increase in the basal secretion of C-peptide as a result of the use of the artificial pancreas.


Asunto(s)
Glucemia/análisis , Péptido C/sangre , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Glucagón/sangre , Sistemas de Infusión de Insulina , Adolescente , Adulto , Diabetes Mellitus Tipo 1/sangre , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Factores de Tiempo
18.
Probl Endokrinol (Mosk) ; 31(2): 3-5, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-3991482

RESUMEN

The authors present for the first time their results concerned with the determination of selective proteinurea by disc electrophoresis in polyacrylamide gel in patients with insulin-dependent and insulin-independent diabetes mellitus with and without the clinical signs of kidney affection. A study was made of the uroproteinograms of these patients before and after the correction of carbohydrate metabolism by means of programmed insulin administration. A conclusion was made of a possibility to use the above method for early detection of diabetic nephropathies. Programmed insulin administration using the Biostator apparatus was shown to improve tubuloglomerular functions, that was expressed in the lowering of proteinurea and in some cases in the improving of the qualitative composition of uroproteins.


Asunto(s)
Diabetes Mellitus Tipo 1/orina , Diabetes Mellitus Tipo 2/orina , Sistemas de Infusión de Insulina , Proteinuria/orina , Adolescente , Adulto , Anciano , Enfermedad Crónica , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Nefropatías Diabéticas/diagnóstico , Nefropatías Diabéticas/orina , Electroforesis en Gel de Poliacrilamida , Femenino , Humanos , Hipertensión/orina , Masculino , Persona de Mediana Edad , Síndrome , Factores de Tiempo
19.
Ter Arkh ; 57(12): 12-6, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-4089761

RESUMEN

The clinicofunctional characteristics of the kidneys were estimated, biopsy of the kidney and skin with an immunohistochemical study was performed and some immunity values considered in 17 patients with type I diabetes mellitus. The study was performed with respect to the degree of expression of the clinical signs of nephropathy including the preclinical stage, too. Three types of morphological changes in the kidney and skin were singled out. Initial tubuloglomerular disorders occurred at the preclinical stage of nephroangiopathy. The nature of changes in the skin coincided mostly with changes in the kidney lagging behind in some cases. The results confirmed the leading role of metabolic derangements in the genesis of microangiopathies and a necessity of a good compensation of diabetes for its prevention. The immunohistochemical and immunological findings did not make it possible to exclude the immune mechanisms in the development of diabetic nephroangiopathy.


Asunto(s)
Diabetes Mellitus Tipo 1/complicaciones , Angiopatías Diabéticas/diagnóstico , Nefropatías Diabéticas/diagnóstico , Glomerulonefritis/diagnóstico , Glomeruloesclerosis Focal y Segmentaria/diagnóstico , Adolescente , Adulto , Angiopatías Diabéticas/clasificación , Nefropatías Diabéticas/clasificación , Glomeruloesclerosis Focal y Segmentaria/clasificación , Humanos , Glomérulos Renales/patología , Microcirculación/patología , Persona de Mediana Edad , Piel/irrigación sanguínea , Enfermedades Vasculares/diagnóstico
20.
Probl Endokrinol (Mosk) ; 30(6): 18-22, 1984.
Artículo en Ruso | MEDLINE | ID: mdl-6514680

RESUMEN

Phagocytic function of polymorphonuclear leukocytes was studied in patients with insulin-dependent and insulin-independent diabetes. A total of 52 patients were examined; the patients were mainly young, suffering from insulin-dependent diabetes with or without angiopathies. The leukocyte phagocytic activity was studied with the use of the direct method developed by G. I. Podoprigora and V. N. Andreev in 1976. All phagocytosis parameters were shown to be reduced, the relationship between these parameters distorted, and digestion impaired, especially in patients with diabetic functional angiopathy and with the Kimmelstiel-Wilson syndrome. A trial is described of correcting phagocytosis disorders by means of a Biostator apparatus (an artificial pancreas, functioning according to the feedblack principle). Such investigation was the first attempted in this country, no data on the leukocyte phagocytic activity before and after treatment with the use of an artificial pancreas apparatus were reported in foreign literature. Clinical application of the method is described.


Asunto(s)
Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 2/inmunología , Neutrófilos/inmunología , Fagocitosis , Adolescente , Adulto , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Angiopatías Diabéticas/inmunología , Femenino , Estudios de Seguimiento , Humanos , Técnicas In Vitro , Sistemas de Infusión de Insulina , Masculino , Persona de Mediana Edad , Staphylococcus aureus/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA